Co-Authored By:
Subsequently, one may also ask, how much is the cancer industry worth 2019?
Jan 30, 2019 (Heraldkeeper via COMTEX)--According to Coherent Market Insights, the globaloncologydrugs market was valued at US$ 77.3 billionin 2018,and is projected to exhibit a CAGR of 12.3% during theforecastperiod (2018 - 2026).
Just so, how much is the cancer industry worth?
The global cancer therapeutics market shouldreach$172.6 billion by 2022 from $121 billion in2017 at acompound annual growth rate (CAGR) of 7.4%, from 2017 to2022. Lungcancer as a segment is expected to grow from$15.7billion in 2017 to $22.6 billion in 2022 at aCAGR of7.6% for the period 2017-2022.
Proclinical has compiled the top 10 list of bestcancerdrugs in 2018, thanks to their outstanding success so farintreating various types of cancer.
- Neulasta. $1.11 bn. Amgen.
- Ibrance. $1.13 bn. Pfizer.
- Opdivo. $1.8 bn. Bristol Myers Squibb.
- Zytiga. $3.5 bn.
- Keytruda. $7.2 bn.
- Avastin. $7.7 bn.
- Herceptin. $7.9 bn.
- Revlimid. $9.8 bn.